Peplin announces positive results of skin cancer trial

	Tweet

Peplin Limited today announced positive results from its Australian phase IIa clinical trial of its proprietary drug PEP005 Topical in superficial forms of basal cell carcinoma (sBCC) the most common form of skin cancer.

The phase IIa clinical trial achieved its objectives. Just two applications of PEP005 Topical (0.05%) gel on two consecutive days cleared 71% of sBCC tumours. This result was statistically significant (p=0.02). In addition PEP005 Topical gel had a favourable safety profile and was well tolerated. The majority of local skin responses reported were graded mild or moderate.

Managing Director & CEO Michael Aldridge said these positive results were a significant milestone for the company and of great interest to people with skin cancers in Australia and worldwide.

"The results of this Australian clinical trial exceeded our expectations,” Mr Aldridge said.

“While we achieved the primary purpose of the trial which was to establish the safety of the drug in treating non-melanoma skin cancers, we have shown that two consecutive days of treatment with PEP005 Topical gel can clear nearly three quarters of basal cell carcinomas, the most common form of skin cancer.

“Our next steps will be to undertake larger trials in Australia and the US starting later this year in order to make application to obtain regulatory approval to market the product as quickly as possible.”

http://www.peplin.com

RELATED STORIES:
Relatives of melanoma patients ignore their skin cancer risk   Gene therapy beats skin cancer in two men   Biomarker test shows promise for melanoma diagnosis   Minorities Need to Put their Best Foot Forward to Prevent Skin Cancer   Certain pain medications do not appear to be associated with skin cancer risk   Multiple skin cancer risk behaviors are common among US adults   Melanoma overdiagnosed in US   Loyola Dermatologists To Offer Free Skin Cancer Screenings   Skin Cancer Facts from M. D. Anderson Cancer Center   Skin cancer study uncovers new tumor suppressor gene   New Option for Patients with Metastatic Melanoma   Early Diagnosis Key to Melanoma Cure   Loyola Dermatologists To Offer Free Skin Cancer Screenings   Emerging Therapies for Skin Cancer Treatment   Green Tea Helps   Minimizing the Risk of Melanoma   Melanoma Is on the Rise in Women   Researchers discover scent of skin cancer   One melanoma means there’s a 15% risk of another   Few People Over 50 Receive Skin Cancer Screenings   Screening finds skin cancer, but does it save lives?   Intervention can protect teens from skin cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]